AlphAIAlphAI — Financial news for AI agents
worldfootwear.comSEP 102 min read

Caleres posts second-quarter sales growth as Brand Portfolio gains momentum

Caleres reported Q2 2026 net sales of $653.0M, up 5.6% YoY. Brand portfolio sales rose 23.6% YoY, while Famous Footwear declined 6.3%. GAAP gross margin increased 1,140 bps to 54.8%. Net earnings were $58.6M, or $1.71 per diluted share. The company raised its full-year EPS guidance.

Original reporting
worldfootwear.com
Published Sep 10, 2026, 12:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 5:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CAL
Relevance
8/10
AlphAI data visualization · based on worldfootwear.com
Decision brief

The 30-second read

Med
01

Why it matters

The earnings beat and guidance raise suggest stronger demand and margin recovery, potentially prompting analysts to upgrade the stock.

02

Market read

First‑quarter earnings and guidance update for a mid‑cap consumer discretionary company.

03

What to watch

Tariff refund boost to gross margin may be non‑recurring.

Relevance 8/10Novelty 8/10Timing: post‑Q2 2026 earnings release

Background

Caleres is a U.S. footwear retailer operating brands such as Stuart Weitzman and Famous Footwear.

Market effects

Sector

Footwear sector may see broader optimism as Caleres lifts guidance.

Regional

U.S. consumer discretionary stocks could benefit from the upbeat earnings.

Global

Limited to U.S. retail and footwear markets.

Counterpoint

What could challenge this read

Famous Footwear weakness could weigh on overall performance if the trend persists.

Key entities

  • Executive
    Jay Schmidt

    President and CEO of Caleres, provided commentary on results.

Read at source← All news

Also covered by

3 outlets

Related articles

SEP 15
$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 2026 results with net sales up 5.6% YoY to $695.5M, but organic sales excluding Stuart Weitzman declined 0.8%. Brand Portfolio sales grew 8.2% with margin expansion, while Famous Footwear sales fell 6.3%. Adjusted EPS rose to $0.47. The company raised full-year EPS guidance to $1.50-$1.65. Management highlights strategic shift to premium brands and higher-margin channels.

news.alphastreet.com3 min
SEP 12
$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 net sales of $695.5M, up 5.6%, and adjusted EPS of $0.47, up from $0.35. Its brand portfolio, including Sam Edelman and Stuart Weitzman, saw sales rise 23.6%, while Famous Footwear sales fell 6.3%. The company raised its full-year guidance but cited inventory and tariff uncertainties.

yahoo.com3 min
SEP 10
$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

fool.com6 min
SEP 9
$CALHighAI 8/10

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.

financialcontent.com2 min
SEP 9
$CALMedAI 8/10

Caleres Q2 Earnings Call Highlights

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.

yahoo.com2 min